Second-line option for metastatic RCC

被引：0
|
作者：
Vanessa Marchesi
机构：
来源：
Nature Reviews Clinical Oncology | 2013年 / 10卷 / 6期
关键词：
D O I：
10.1038/nrclinonc.2013.74
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：305 / 305
相关论文
共 50 条
  • [31] Second-line chemotherapy in older patients with metastatic urothelial carcinoma: Pooled analysis of 10 second-line studies.
    Salah, Samer
    Lee, Jae-Lyun
    Rozzi, Antonio
    Lewin, Jeremy Howard
    Kitamura, Hiroshi
    Matsumoto, Kazumasa
    Vis, Daniel J.
    Wessels, Lodewyk F. A.
    Srinivas, Sandy
    Morales, Rafael
    Carles, Joan
    Toubasi, Samar
    Lee, Soonil
    Kim, Ki Hong
    Izumi, Kouji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Comparative analysis of the effectiveness of second-line bevacizumab plus chemotherapy in second-line therapy in metastatic colorectal cancer.
    Smagulova, Kaldigul
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [33] AXIS trial data confirm axitinib as second-line option for mRCC
    Sarah Payton
    Nature Reviews Urology, 2013, 10 (6) : 308 - 308
  • [34] Pembrolizumab: A reliable second-line treatment option for advanced esophageal cancer
    Zheng, Li
    Zhu, Yabi
    Liu, Yangyang
    Ma, Xu
    Xu, Fang
    THORACIC CANCER, 2022, 13 (08) : 1233 - 1233
  • [35] Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
    Aldo Castagnari
    BMC Proceedings, 2 (Suppl 2)
  • [36] Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?
    Aprile, Giuseppe
    Negri, Francesca V.
    Giuliani, Francesco
    De Carlo, Elisa
    Melisi, Davide
    Simionato, Francesca
    Silvestris, Nicola
    Brunetti, Oronzo
    Leone, Francesco
    Marino, Donatella
    Santini, Daniele
    Dell'Aquila, Emanuela
    Zeppola, Tea
    Puzzoni, Marco
    Scartozzi, Mario
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 115 : 1 - 12
  • [37] Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence
    De Luca, Emmanuele
    Marino, Donatella
    Di Maio, Massimo
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3721 - 3729
  • [38] How Do You Choose a Second-Line Treatment Option for Depression?
    Weisler, Richard H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 : 21 - 26
  • [39] Cost utility in second-line metastatic breast cancer - Reply
    Launois, R
    ReboulMarty, J
    Henry, B
    Bonneterre, J
    PHARMACOECONOMICS, 1997, 11 (05) : 495 - 497
  • [40] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
12345